1-248038331-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001385855.1(OR2L2):c.64A>T(p.Ile22Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000645 in 1,612,828 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001385855.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR2L2 | NM_001385855.1 | c.64A>T | p.Ile22Phe | missense_variant | 3/3 | ENST00000641771.1 | NP_001372784.1 | |
OR2L2 | NM_001004686.3 | c.64A>T | p.Ile22Phe | missense_variant | 2/2 | NP_001004686.1 | ||
OR2L13 | NM_001304535.3 | c.-18-61027A>T | intron_variant | NP_001291464.1 | ||||
OR2L13 | NM_175911.5 | c.-143-60320A>T | intron_variant | NP_787107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR2L2 | ENST00000641771.1 | c.64A>T | p.Ile22Phe | missense_variant | 3/3 | NM_001385855.1 | ENSP00000493410.1 | |||
OR2L2 | ENST00000366479.4 | c.64A>T | p.Ile22Phe | missense_variant | 1/1 | 6 | ENSP00000355435.2 | |||
OR2L2 | ENST00000642011.1 | c.64A>T | p.Ile22Phe | missense_variant | 2/2 | ENSP00000493154.1 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152172Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000677 AC: 17AN: 250986Hom.: 0 AF XY: 0.0000663 AC XY: 9AN XY: 135646
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1460538Hom.: 0 Cov.: 30 AF XY: 0.0000399 AC XY: 29AN XY: 726680
GnomAD4 genome AF: 0.000295 AC: 45AN: 152290Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74472
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.64A>T (p.I22F) alteration is located in exon 1 (coding exon 1) of the OR2L2 gene. This alteration results from a A to T substitution at nucleotide position 64, causing the isoleucine (I) at amino acid position 22 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at